"That is very different from a drug actually causing a new cancer." The review emphasizes that for patients with papillary, follicular, or Oncocytic (Hrthle cell) thyroid cancers, current evidence does not support the idea that GLP-1 medications cause these diseases or worsen their course
We may receive compensation from the companies featured on this site
This opens the door for generic versions to enter the market
Weeks 12: Digestion calms, discomfort decreases, energy improves
Semaglutide, a GLP-1 agonist initially developed for diabetes management, has gained attention for its ability to promote significant weight loss
Summary: Wegovy (semaglutide) and escitalopram (Cipralex) can generally be taken together safely, as no contraindication is listed in UK product information